US Oncology Therapeutics Market Analysis

US Oncology Therapeutics Market Analysis


$ 3999

The US oncology therapeutics market is projected to grow from $83 Bn in 2022 to $172 Bn by 2030, registering a CAGR of 9.6% during the forecast period of 2022-30. The development of new and innovative cancer treatments, such as immunotherapies and targeted therapies, is driving the growth of the oncology therapeutics market. This market is highly competitive, with many large pharmaceutical companies and biotech companies competing for market share. Some of the major players in the market include Roche, Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, AstraZeneca, and Johnson & Johnson

ID: IN10USPH042 CATEGORY: Pharmaceuticals GEOGRAPHY: US AUTHOR: Shivam Zalke

Buy Now

US Oncology Therapeutics Market Executive Summary

The US oncology therapeutics market is projected to grow from $83 Bn in 2022 to $172 Bn by 2030, registering a CAGR of 9.6% during the forecast period of 2022-30.

Its market can be segmented into several categories based on the type of cancer, the type of therapy, and the distribution channel. The most common types of cancer treated in this market include breast cancer, lung cancer, prostate cancer, colorectal cancer, and leukemia.

The therapies used to treat these cancers can be broadly categorized into chemotherapy, targeted therapy, immunotherapy, and radiation therapy. The chemotherapy segment is the largest segment of the market, but immunotherapy is the fastest-growing segment due to the high demand for more effective and less toxic treatments.

It is also segmented based on the distribution channel, including hospital pharmacies, retail pharmacies, and online pharmacies.

The market is highly competitive, with many large pharmaceutical companies and biotech companies competing for market share. Some of the major players in the market include Roche, Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, AstraZeneca, and Johnson & Johnson.

US oncology therapeutics market analysis

Market Dynamics

The US oncology therapeutics market is driven by various factors, including:

Growing incidence of cancer: The US has one of the highest rates of cancer incidence in the world, with over 1.8 Mn new cases of cancer diagnosed each year. This increasing prevalence of cancer is driving the demand for oncology therapeutics.

Advancements in cancer research: The development of new and innovative cancer treatments, such as immunotherapies and targeted therapies, is driving the growth of the oncology therapeutics market. Ongoing research in the field of oncology is also leading to the development of new drugs and therapies that are more effective and have fewer side effects.

Aging population: The US population is aging, with a large number of baby boomers reaching retirement age. As people age, the risk of cancer increases, which is driving the demand for oncology therapeutics.

Favorable healthcare policies: The Affordable Care Act has expanded healthcare coverage and increased access to cancer treatments for many Americans. This has led to an increase in the demand for oncology therapeutics.

Increasing use of combination therapies: Combination therapies, which involve the use of multiple drugs or therapies to treat cancer, are becoming more common in the treatment of many types of cancer. This trend is driving the demand for oncology therapeutics.

Strong pipeline of new drugs: Many pharmaceutical companies are investing heavily in oncology research and development, which has led to a strong pipeline of new drugs and therapies for the treatment of cancer. This is expected to drive the growth of the oncology therapeutics market in the coming years.

Overall, its market is driven by a combination of demographic, scientific, and policy factors that are expected to continue driving growth in the market in the years to come.

Competitive Landscape

Key Players

The US oncology therapeutics market is highly competitive, with many key players competing for market share. Here are some of the key players in the US oncology therapeutics market:

  • Roche: Roche is a Swiss multinational healthcare company that develops and markets oncology therapeutics, including targeted therapies, immunotherapies, and chemotherapy drugs
  • Pfizer: Pfizer is a multinational pharmaceutical company that develops and markets oncology therapeutics, including targeted therapies and chemotherapy drugs
  • Merck: Merck is a multinational pharmaceutical company that develops and markets oncology therapeutics, including immunotherapies, targeted therapies, and chemotherapy drugs
  • Bristol-Myers Squibb: Bristol-Myers Squibb is a multinational pharmaceutical company that develops and markets oncology therapeutics, including immunotherapies and targeted therapies
  • Novartis: Novartis is a Swiss multinational healthcare company that develops and markets oncology therapeutics, including targeted therapies and chemotherapy drugs
  • Amgen: Amgen is a biotechnology company that develops and markets oncology therapeutics, including immunotherapies and targeted therapies
  • AstraZeneca: AstraZeneca is a multinational pharmaceutical company that develops and markets oncology therapeutics, including targeted therapies and chemotherapy drugs
  • AbbVie: AbbVie is a biopharmaceutical company that develops and markets oncology therapeutics, including targeted therapies and chemotherapy drugs
  • Eli Lilly and Company: Eli Lilly and Company is a multinational pharmaceutical company that develops and markets oncology therapeutics, including targeted therapies and chemotherapy drugs
  • Johnson & Johnson: Johnson & Johnson is a multinational healthcare company that develops and markets oncology therapeutics, including targeted therapies and chemotherapy drugs

Overall, these key players are focused on developing and commercializing innovative cancer treatments, including immunotherapies, targeted therapies, and combination therapies, with the aim of improving patient outcomes and capturing market share.

Healthcare Policies and Regulatory Landscape

The US oncology therapeutics market is regulated by a number of healthcare policies and regulations aimed at ensuring the safety and efficacy of cancer treatments.

Here are some key policies and regulations that impact its market:

Food and Drug Administration (FDA): The FDA is responsible for regulating the development, approval, and marketing of drugs and medical devices, including oncology therapeutics. The FDA reviews clinical trial data and approves new drugs for use in the US market based on their safety and efficacy.

Medicare: Medicare is a federal health insurance program that covers the cost of healthcare services for eligible individuals aged 65 and over, as well as people with certain disabilities. Medicare covers many cancer treatments, including chemotherapy and radiation therapy.

Affordable Care Act (ACA): The ACA has expanded healthcare coverage and increased access to cancer treatments for many Americans. The law includes provisions that require health insurance plans to cover cancer screening tests and treatments, and it prohibits insurers from denying coverage to people with pre-existing conditions, including cancer.

National Cancer Institute (NCI): The NCI is a federal agency that conducts and supports cancer research, training, and education. The NCI provides funding for research on new cancer treatments, as well as clinical trials to test the safety and efficacy of new drugs and therapies.

Centers for Medicare and Medicaid Services (CMS): The CMS is responsible for administering the Medicare and Medicaid programs, as well as implementing regulations related to healthcare reimbursement. The CMS sets reimbursement rates for cancer treatments and implements policies related to value-based care, which aims to improve patient outcomes while reducing healthcare costs.

Overall, the US oncology therapeutics market is heavily regulated, with numerous policies and regulations in place to ensure the safety and efficacy of cancer treatments. These policies and regulations are aimed at improving patient outcomes and increasing access to cancer care, while also controlling healthcare costs.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Oncology Therapeutics Market Segmentation

By Application (Revenue, USD Billion):

  • Blood Cancer
  • Colorectal Cancer
  • Gastrointestinal Cancer
  • Gynaecologic Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • ?Others

By Drugs (Revenue, USD Billion):

  • Revlimid
  • Avastin
  • Herceptin
  • Rituxan
  • Opdivo
  • Gleevec
  • Velcade
  • Imbruvica
  • Ibrance
  • Zytiga
  • Alimta
  • Xtandi
  • Tarceva
  • Perjeta
  • Temodar
  • Others

By Therapy (Revenue, USD Billion):

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Hormonal Therapy
  • Others

By Route of Administration (Revenue, USD Billion):

  • Oral
  • Parenteral
  • Others

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 05 March 2023
Updated by: Jay Dalwadi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up